One ticker, one page: health score, red flags, fundamentals, who’s buying, cash & dilution, and the latest catalyst — every module built from SEC filings, ready to print or share.
start from a preset — you get the bundle, then edit it
or pick exactly what you want — 5 selected
These add one extra lookup each — still fine to combine.
Heavy modules — each one runs on its own. Checking one clears the rest, because it reads several filings live and would otherwise time the page out.
Your selection lives in the link, so a built report is shareable and bookmarkable. Educational information from public filings — not investment advice.
Assembling INTZ’s research report…
Pulling SEC filings
Parsing XBRL fundamentals
Scoring quality, value & momentum
Checking who’s buying
Rendering
INTZ INTRUSION INC.
Research report · from SEC EDGAR · close 2026-11-02
$0.56 -3.6%
$13.7M mkt cap
Close: REPORTED End-of-day closing price; as of 2026-11-02. No single source document identified.
Market cap: DERIVED Last close times filed shares outstanding, dei:EntityCommonStockSharesOutstanding; as of close 2026-11-02; count as of 2026-08-11; Form 10-Q 0001683168-26-006209, filed 2026-08-11.
INTRUSION INC. (INTZ) is a $13.7M company. Revenue is $7.1M (+22.9% y/y) at a -0% net margin. It is not yet profitable. Our health score is F (16/100). 3 red flags on file. Smart money is buying (2 insider). It may need to raise cash (dilution risk).
Market cap: DERIVED Last close times filed shares outstanding, dei:EntityCommonStockSharesOutstanding; as of close 2026-11-02; count as of 2026-08-11; Form 10-Q 0001683168-26-006209, filed 2026-08-11.
Revenue and growth: REPORTED SEC XBRL companyfacts, us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; as of FY ending 2025-12-31; Form 10-K 0001683168-26-002196, filed 2026-03-25.
Net margin: UNVALIDATED Net income over revenue, from SEC XBRL companyfacts; as of FY ending 2025-12-31. Method not verified against an independent source.
Net income: REPORTED SEC XBRL companyfacts, us-gaap:NetIncomeLoss; as of FY ending 2025-12-31; Form DEF 14A 0001683168-26-005636, filed 2026-07-20.
Health score: UNVALIDATED StockTools.ai health score, from SEC XBRL companyfacts and end-of-day prices; as of scores FY ending 2025-12-31; cash as of 2026-06-30; trend at close 2026-11-02. Method not verified against an independent source.
REPORTED SEC XBRL companyfacts, us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; as of FY ending 2025-12-31; Form 10-K 0001683168-26-002196, filed 2026-03-25.
Net income
$-9,059
REPORTED SEC XBRL companyfacts, us-gaap:NetIncomeLoss; as of FY ending 2025-12-31; Form DEF 14A 0001683168-26-005636, filed 2026-07-20.
Net margin
-0.1%
UNVALIDATED Net income over revenue, from SEC XBRL companyfacts; as of FY ending 2025-12-31. Method not verified against an independent source.
EPS (diluted)
$-0.46
REPORTED SEC XBRL companyfacts, us-gaap:EarningsPerShareDiluted; as of FY ending 2025-12-31; Form 10-K 0001683168-26-002196, filed 2026-03-25.
Piotroski F
2/9
UNVALIDATED Piotroski F-Score, computed from SEC XBRL companyfacts; as of FY ending 2025-12-31, against FY ending 2024-12-31.
Auditor flagged substantial doubt about the company continuing for the next 12 months — a raise is usually required.
REPORTED SEC full-text search for "substantial doubt" in 10-K and 10-Q filings; as of filed 2025-07-31 to 2026-11-03.
⛔
Bankruptcy-risk zone
Altman Z-Score is in the distress zone (-16.43).
UNVALIDATED Altman Z-Score, computed from SEC XBRL companyfacts; as of FY ending 2025-12-31, against FY ending 2024-12-31. Method not verified against an independent source.
⚠
Weak fundamentals
Piotroski F-Score of 2/9 — most quality checks are failing.
UNVALIDATED Piotroski F-Score, computed from SEC XBRL companyfacts; as of FY ending 2025-12-31, against FY ending 2024-12-31. Method not verified against an independent source.
who's buying
Insider buys / sells
2 / 1
DERIVED SEC Form 4, open-market purchases (P) and sales (S); as of filed 2026-07-07 to 2026-09-04.
Congress buys
0
DERIVED Periodic transaction reports filed under the STOCK Act; as of no report in the window read. No single source document identified; no as-of date carried.
13F fund holders
0
DERIVED SEC Form 13F-HR, the funds we track; as of no tracked fund reports a position. No single source document identified; no as-of date carried.
No per-share dividend series in INTZ’s filings — either it pays none, or it doesn’t report the tag we read. We show nothing rather than estimate.
Assembled from SEC EDGAR (XBRL, Form 4, 13F, filings), STOCK Act disclosures, and end-of-day prices. Each figure prints its own source and the date it is true as of beneath it, with REPORTED for a figure the source published and DERIVED or UNVALIDATED for our arithmetic; nothing is fabricated or predicted. Filings lag 40 to 90 days. Educational, not investment advice. Generated 2026-11-03 by stocktools.ai.
Insider counts: DERIVED SEC Form 4, open-market purchases (P) and sales (S); as of filed 2026-07-07 to 2026-09-04.
Congress counts: DERIVED Periodic transaction reports filed under the STOCK Act; as of no report in the window read. No single source document identified; no as-of date carried.
Fund holders: DERIVED SEC Form 13F-HR, the funds we track; as of no tracked fund reports a position. No single source document identified; no as-of date carried.
Cash need: DERIVED Cash divided by operating burn, from SEC XBRL companyfacts; as of cash as of 2026-06-30; operating cash flow over FY ending 2025-12-31.
Method not verified against an independent source.
Altman Z
distress
UNVALIDATED Altman Z-Score, computed from SEC XBRL companyfacts; as of FY ending 2025-12-31, against FY ending 2024-12-31. Method not verified against an independent source.